Inventor · disambiguated record
James Karras
Also filed as: KARRAS JAMES · KARRAS JAMES G · KARRAS JAMES GERARD
21 granted patents·23 pending applications·870 citations·filing 1999–2014
96Inventor score
Top patents by PatentIndex Score
44 records- 0198US7235653B2Oligonucleotide compositions and methods for the modulation of the expression of B7 proteinISIS PHARMACEUTICALS INC·Filed 2003·Granted Jun 26, 2007·117 cites·11 claims
- 0298US6210892B1Alteration of cellular behavior by antisense modulation of mRNA processingISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 3, 2001·358 cites·31 claims
- 0397US7033830B2Antisense modulation of MyD88 expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Apr 25, 2006·94 cites·13 claims
- 0495US7307069B2Antisense oligonucleotide modulation of STAT3 expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted Dec 11, 2007·23 cites·13 claims
- 0594US7176303B2Modulation of STAT5 expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Feb 13, 2007·42 cites·8 claims
- 0691US7507810B2Compositions and their uses directed to IL-4R alphaISIS PHARMACEUTICALS INC·Filed 2006·Granted Mar 24, 2009·14 cites·11 claims
- 0791US6136603AAntisense modulation of interleukin-5 signal transductionISIS PHARMACEUTICALS INC·Filed 1999·Granted Oct 24, 2000·72 cites·32 claims
- 0890US6727064B2Antisense oligonucleotide modulation of STAT3 expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Apr 27, 2004·33 cites·15 claims
- 0986US8183363B2Antisense oligonucleotide modulation of STAT3 expressionKARRAS JAMES G·Filed 2009·Granted May 22, 2012·6 cites·15 claims
- 1086US7098192B2Antisense oligonucleotide modulation of STAT3 expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Aug 29, 2006·15 cites·21 claims
- 1186US6159694AAntisense modulation of stat3 expressionISIS PHARMACEUTICALS INC·Filed 1999·Granted Dec 12, 2000·56 cites·23 claims
- 1285US8168600B2Compositions and methods for topical delivery of oligonucleotidesDOKKA SUJATHA·Filed 2005·Granted May 1, 2012·19 cites·21 claims
- 1383US7709628B2Modulation of STAT5 expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted May 4, 2010·4 cites·22 claims
- 1483US7585968B2Compositions and their uses directed to thymus and activation-regulated chemokine (TARC)ISIS PHARMACEUTICALS INC·Filed 2006·Granted Sep 8, 2009·4 cites·30 claims
- 1580US8623643B2Antisense oligonucleotide modulation of STAT3 expressionKARRAS JAMES G·Filed 2012·Granted Jan 7, 2014·3 cites·11 claims
- 1677US7115580B1Antisense modulation of B7 protein expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Oct 3, 2006·4 cites·40 claims
- 1775US8722873B2Modulation of stat5 expressionFREIER SUSAN M·Filed 2010·Granted May 13, 2014·1 cites·24 claims
- 1875US7981868B2Antisense modulation of p38 mitogen activated protein kinase expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 19, 2011·3 cites·13 claims
- 1974US8765700B2Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditionsTACHAS GEORGE·Filed 2005·Granted Jul 1, 2014·2 cites·14 claims
- 2067US2009281169A1Compositions and Their Uses Directed to IL-4R AlphaISIS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2161US2010202977A9Modulation of Stat 6 Expression for the Treatment of Airway HyperresponsivenessKARRAS JAMES·Filed 2006·Application pending·0 cites
- 2261US2005227938A1Antisense modulation of TFAP2C expressionBENNETT C F·Filed 2004·Application pending·0 cites
- 2361US2008051359A1Antisense oligonucleotide modulation of stat3 expressionKARRAS JAMES G·Filed 2007·Application pending·0 cites
- 2459US2009023599A1Use of antisense oligonucleotide libraries for identifying gene functionISIS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2558US2006099613A1Use of antisense oligonucleotide libraries for identifying gene functionISIS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2657US8153603B2Compositions and their uses directed to IL-4R alphaKARRAS JAMES G·Filed 2006·Granted Apr 10, 2012·0 cites·20 claims
- 2755US2010222231A1Use of antisense oligonucleotide libraries for identifying gene functionISIS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2855US2003054354A1Use of antisense oligonucleotide libraries for identifying gene functionFiled 2001·Application pending·0 cites
- 2954US2004121376A1Antisense modulation of interleukin-5 signal transductionFiled 2003·Application pending·0 cites
- 3054US2012316221A1Compositions and their uses directed to il-4r alphaKARRAS JAMES G·Filed 2012·Application pending·0 cites
- 3153US2006258610A1Modulation of STAT 6 expression for the treatment of airway hyperresponsivenessISIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3252US2003186903A1Antisense modulation of MyD88 expressionISIS PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
- 3350US2004023917A1Oligonucleotide compositions and methods for the modulation of the expression of B7 proteinFiled 2003·Application pending·0 cites
- 3449US2002128216A1Antisense modulation of interleukin-5 signal transductionFiled 2001·Application pending·0 cites
- 3547US2003232440A1Antisense modulation of STAT1 expressionISIS PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 3645US2010056606A1Combination therapy using budesonide and antisense oligonucleotide targeted to IL4-receptor alphaISIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3745US2005215504A1Antisense modulation of sterol regulatory element-binding protein-1 expressionBENNETT C F·Filed 2004·Application pending·0 cites
- 3845US2003144225A1Antisense modulation of macrophage inflammatory protein 3-alpha expressionFiled 2001·Application pending·0 cites
- 3944US2003125272A1Antisense modulation of toll-like receptor 4 expressionFiled 2001·Application pending·0 cites
- 4044US2002049173A1Alteration of cellular behavior by antisense modulation of mRNA processingFiled 2000·Application pending·0 cites
- 4144US2003176374A1Oligonucleotide compositions and methods for the modulation of the expression of B7 proteinFiled 2001·Application pending·0 cites
- 4243US2005215506A1Modulation of tyrosinase expressionBENNETT C F·Filed 2005·Application pending·0 cites
- 4340US9776211B2Methods of filling wood voids and reducing waste in production of coated wood productsANDERSEN CORP·Filed 2014·Granted Oct 3, 2017·0 cites·23 claims
- 4440US2012309815A1Compositions and methods for topical delivery of oligonucleotidesDOKKA SUJATHA·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Karras files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →